Efficacy News and Research

RSS
New findings on STEP HIV vaccine trial

New findings on STEP HIV vaccine trial

YM Biosciences reports on early trials of nimotuzumab in brain metastases and high-grade glioma

YM Biosciences reports on early trials of nimotuzumab in brain metastases and high-grade glioma

Pfizer's Toviaz (fesoterodine fumarate) receives FDA approval for the treatment of overactive bladder

Pfizer's Toviaz (fesoterodine fumarate) receives FDA approval for the treatment of overactive bladder

Cimzia study shows reduction of symptoms and progression of rheumatoid arthritis

Cimzia study shows reduction of symptoms and progression of rheumatoid arthritis

GlaxoSmithKline believes there is no liver safety issue with Avandia (rosiglitazone maleate)

GlaxoSmithKline believes there is no liver safety issue with Avandia (rosiglitazone maleate)

GSK to acquire Genelabs Technologies

GSK to acquire Genelabs Technologies

FDA grants tentative approval for 75th generic anti-retroviral drug

FDA grants tentative approval for 75th generic anti-retroviral drug

How drug companies covertly promote off-label drug use

How drug companies covertly promote off-label drug use

Scientists discover a catalytic antibody that degrades a known appetite stimulant

Scientists discover a catalytic antibody that degrades a known appetite stimulant

Nanocort demonstrates safety and good response in phase I/II trial for rheumatoid arthritis

Nanocort demonstrates safety and good response in phase I/II trial for rheumatoid arthritis

Sunesis Pharmaceuticals updates clinical data on Voreloxin in platinum-resistant ovarian cancer

Sunesis Pharmaceuticals updates clinical data on Voreloxin in platinum-resistant ovarian cancer

Targanta Therapeutics presents preclinical data on Oritavancin against Clostridium difficile infection

Targanta Therapeutics presents preclinical data on Oritavancin against Clostridium difficile infection

Kamada completes final analysis of phase III trial with intravenous Alpha-1 Antitrypsin (AAT), for hereditary AAT deficiency

Kamada completes final analysis of phase III trial with intravenous Alpha-1 Antitrypsin (AAT), for hereditary AAT deficiency

Nymox nears completion of benign prostatic hyperplasia drug trial

Nymox nears completion of benign prostatic hyperplasia drug trial

ZymoGenetics presents interim Interleukin 21 phase 2 results in renal cell cancer

ZymoGenetics presents interim Interleukin 21 phase 2 results in renal cell cancer

Peregrine Pharmaceuticals reports on phase II trial of Bavituximab plus Docetaxel in advanced breast cancer

Peregrine Pharmaceuticals reports on phase II trial of Bavituximab plus Docetaxel in advanced breast cancer

Genentech announces phase III study of Avastin plus chemotherapy in adjuvant colon cancer will continue

Genentech announces phase III study of Avastin plus chemotherapy in adjuvant colon cancer will continue

Polio could be wiped out in Nigeria thanks to improved vaccine

Polio could be wiped out in Nigeria thanks to improved vaccine

Brain-derived neurotrophic factor may predict schizophrenia relapse

Brain-derived neurotrophic factor may predict schizophrenia relapse

Biothera initiates second phase of metastatic colorectal cancer trial

Biothera initiates second phase of metastatic colorectal cancer trial

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.